Toronto, Canada

Ines Lohse

This inventor holds 1 USPTO granted patent, plus 5 CIPO patents and 1 EPO patent. Top assignee: University Health Network. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ines Lohse. Retrieved from https://idiyas.com/inventor/ines-lohse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Ines Lohse - Pioneering Pancreatic Cancer Treatment

Introduction: Ines Lohse, a brilliant inventor based in Toronto, Canada, is making waves in the field of oncology with her groundbreaking approach to treating pancreatic cancer.

Latest Patents: With a total of 1 patent under her belt, Ines Lohse's most notable invention revolves around a revolutionary treatment for pancreatic cancer. The patent details a novel method of administering a specific compound to effectively combat this deadly disease.

Career Highlights: Ines Lohse is a key figure at the University Health Network, where she is actively involved in cutting-edge research and development. Her dedication to advancing cancer treatment has positioned her as a leading expert in the field.

Collaborations: In her pursuit of innovation, Ines Lohse collaborates closely with esteemed colleagues such as David Hedley and Jacqueline M Mason. Together, they form a dynamic team driving forward progress in the fight against pancreatic cancer.

Conclusion: Ines Lohse's contributions to the field of oncology, particularly in the realm of pancreatic cancer treatment, exemplify her commitment to improving healthcare outcomes. Her inventive spirit and collaborative efforts stand as a testament to the power of innovation in shaping a better future for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…